Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 1,420 | 1,426 | 1,479 | 1,441 | 1,406 | -- |
| Gross Profit | -1,420 | -1,426 | -1,479 | -1,441 | -1,406 | -- |
| Selling General And Administration | 424,899 | 108,791 | 91,127 | 84,108 | 75,108 | -- |
| General And Administrative Expense | 424,899 | 108,791 | 91,127 | 84,108 | 75,108 | -- |
| Other Operating Expenses | 42,276 | 22,586 | 25,690 | 18,137 | 38,771 | -- |
| Operating Expense | 467,175 | 131,377 | 116,817 | 102,245 | 113,879 | -- |
| Operating Income | -468,595 | -132,803 | -118,296 | -103,686 | -115,285 | -- |
| EBIT | -468,595 | -132,803 | -118,296 | -103,686 | -115,285 | -- |
| Other Income Expense | -9,836 | 19,758 | 304.00 | -19,238 | 3,991 | -- |
| Gain On Sale Of Security | -9,836 | 19,758 | 304.00 | -19,238 | 3,991 | -- |
| Pretax Income | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Net Income From Continuing Operation Net Minority Interest | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Net Income Including Noncontrolling Interests | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Net Income Common Stockholders | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Net Income | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| EBITDA | -466,907 | -131,388 | -116,806 | -101,931 | -113,739 | -- |
| Normalized EBITDA | -457,071 | -151,146 | -117,110 | -82,693 | -117,730 | -- |
| Reconciled Depreciation | 1,688 | 1,415 | 1,490 | 1,755 | 1,546 | -- |
| Basic EPS | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Basic Average Shares | 135.3M | 135.3M | 135.3M | -- | 136.5M | 127.2M |
| Diluted Average Shares | 135.3M | 135.3M | 135.3M | -- | 136.5M | 127.2M |
| Total Unusual Items | -9,836 | 19,758 | 304.00 | -19,238 | 3,991 | -- |
| Total Unusual Items Excluding Goodwill | -9,836 | 19,758 | 304.00 | -19,238 | 3,991 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -468,595 | -132,803 | -118,296 | -103,686 | -115,285 | -- |
| Diluted NI Availto Com Stockholders | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Insurance And Claims | 6,281 | 6,571 | 6,499 | 6,716 | 2,816 | -- |
| Net Income Continuous Operations | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Other Gand A | 73,949 | 102,220 | 84,628 | 77,393 | 72,292 | -- |
| Reconciled Cost Of Revenue | 1,420 | 1,426 | 1,479 | 1,441 | 1,406 | -- |
| Salaries And Wages | 344,669 | 0.00 | 0.00 | -1.00 | 0.00 | -- |
| Total Expenses | 468,595 | 132,803 | 118,296 | 103,686 | 115,285 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 5,522 | 7,651 | 14,683 | 4,382 | 4,512 | -- |
| Cash Cash Equivalents And Short Term Investments | 5,522 | 7,651 | 14,683 | 4,382 | 4,512 | -- |
| Cash Financial | 5,522 | 7,651 | 14,683 | 4,382 | 4,512 | -- |
| Receivables | 2,520 | 4,038 | 3,244 | 2,642 | 3,103 | -- |
| Prepaid Assets | 20,526 | 3,755 | 10,326 | 16,825 | 23,541 | -- |
| Current Assets | 28,568 | 15,444 | 28,253 | 23,849 | 31,156 | -- |
| Net PPE | 12.2M | 12.0M | 12.4M | 12.4M | 10.9M | -- |
| Other Non Current Assets | 178,808 | 175,238 | 184,653 | 184,820 | 173,388 | -- |
| Total Non Current Assets | 12.4M | 12.2M | 12.5M | 12.5M | 11.1M | -- |
| Total Assets | 12.4M | 12.2M | 12.6M | 12.6M | 11.1M | -- |
| Payables And Accrued Expenses | 2.9M | 2.7M | 2.6M | 2.5M | 1.3M | -- |
| Current Liabilities | 2.9M | 2.7M | 2.6M | 2.5M | 1.3M | -- |
| Total Non Current Liabilities Net Minority Interest | 178,808 | 175,238 | 184,653 | 184,820 | 173,388 | -- |
| Total Liabilities Net Minority Interest | 3.1M | 2.8M | 2.8M | 2.7M | 1.5M | -- |
| Common Stock | 74.1M | 74.1M | 74.1M | 74.1M | 74.1M | -- |
| Capital Stock | 74.1M | 74.1M | 74.1M | 74.1M | 74.1M | -- |
| Additional Paid In Capital | 4.9M | 4.6M | 4.6M | 4.6M | 4.6M | -- |
| Retained Earnings | -70.2M | -69.7M | -69.6M | -69.5M | -69.3M | -- |
| Gains Losses Not Affecting Retained Earnings | 527,714 | 397,422 | 741,107 | 747,224 | 329,541 | -- |
| Other Equity Adjustments | 527,714 | 397,422 | 741,107 | 747,224 | 329,541 | -- |
| Common Stock Equity | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Stockholders Equity | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Total Equity Gross Minority Interest | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Total Capitalization | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Net Tangible Assets | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Tangible Book Value | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Working Capital | -2.9M | -2.6M | -2.6M | -2.4M | -1.3M | -- |
| Invested Capital | 9.3M | 9.3M | 9.8M | 9.9M | 9.6M | -- |
| Share Issued | 136.5M | 136.5M | 136.5M | 136.5M | 136.5M | -- |
| Ordinary Shares Number | 136.5M | 136.5M | 136.5M | 136.5M | 136.5M | -- |
| Long Term Provisions | 178,808 | 175,238 | 184,653 | 184,820 | 173,388 | -- |
| Taxes Receivable | 2,520 | 4,038 | 3,244 | 2,642 | 3,103 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -199,856 | 44,251 | 18,341 | 132,488 | -50,845 | -- |
| Cash Flow From Continuing Operating Activities | -199,856 | 44,251 | 18,341 | 132,488 | -50,845 | -- |
| Depreciation And Amortization | 1,688 | 1,415 | 1,490 | 1,755 | 1,546 | -- |
| Depreciation Amortization Depletion | 1,688 | 1,415 | 1,490 | 1,755 | 1,546 | -- |
| Stock Based Compensation | 344,669 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Change In Working Capital | 240,799 | 90,560 | 133,408 | 236,076 | 50,975 | -- |
| Change In Receivables | 1,518 | -794.00 | -602.00 | 461.00 | -2,384 | -- |
| Change In Payables And Accrued Expense | 256,052 | 84,783 | 127,511 | 228,899 | 76,900 | -- |
| Capital Expenditure | -- | -- | -- | -- | -80,673 | -13,202 |
| Purchase Of PPE | -- | -- | -- | -- | -80,673 | -13,202 |
| Net PPE Purchase And Sale | 197,727 | -- | -- | -- | -80,673 | -13,202 |
| Investing Cash Flow | 197,727 | -51,283 | -8,040 | -132,651 | -80,673 | -- |
| Cash Flow From Continuing Investing Activities | 197,727 | -51,283 | -8,040 | -132,651 | -80,673 | -- |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Changes In Cash | -2,129 | -7,032 | 10,301 | -163.00 | -131,518 | -- |
| Beginning Cash Position | 7,651 | 14,683 | 4,382 | 4,512 | 136,030 | -- |
| End Cash Position | 5,522 | 7,651 | 14,683 | 4,382 | 4,512 | -- |
| Free Cash Flow | -140,533 | -15,072 | 18,341 | 132,488 | -131,518 | -- |
| Change In Prepaid Assets | -16,771 | 6,571 | 6,499 | 6,716 | -23,541 | -- |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation | 1,688 | 1,415 | 1,490 | 1,755 | 1,546 | -- |
| Net Foreign Currency Exchange Gain Loss | -308,581 | 65,321 | 1,435 | 17,581 | 7,928 | -- |
| Net Income From Continuing Operations | -478,431 | -113,045 | -117,992 | -122,924 | -111,294 | -- |
| Net Other Investing Changes | -- | -- | -8,040 | -132,651 | -- | -- |
| Operating Gains Losses | -308,581 | 65,321 | 1,435 | 17,581 | 7,928 | -- |
| Proceeds From Stock Option Exercised | -- | -- | -- | -- | -- | 0.00 |